216 related articles for article (PubMed ID: 20591826)
1. Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
Groh J; Heinl K; Kohl B; Wessig C; Greeske J; Fischer S; Martini R
Hum Mol Genet; 2010 Sep; 19(18):3530-43. PubMed ID: 20591826
[TBL] [Abstract][Full Text] [Related]
2. MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy.
Kohl B; Fischer S; Groh J; Wessig C; Martini R
Am J Pathol; 2010 Mar; 176(3):1390-9. PubMed ID: 20093502
[TBL] [Abstract][Full Text] [Related]
3. Cell-Surface and Secreted Isoforms of CSF-1 Exert Opposing Roles in Macrophage-Mediated Neural Damage in Cx32-Deficient Mice.
Groh J; Basu R; Stanley ER; Martini R
J Neurosci; 2016 Feb; 36(6):1890-901. PubMed ID: 26865613
[TBL] [Abstract][Full Text] [Related]
4. CSF-1-activated macrophages are target-directed and essential mediators of Schwann cell dedifferentiation and dysfunction in Cx32-deficient mice.
Groh J; Klein I; Hollmann C; Wettmarshausen J; Klein D; Martini R
Glia; 2015 Jun; 63(6):977-86. PubMed ID: 25628221
[TBL] [Abstract][Full Text] [Related]
5. Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X.
Groh J; Weis J; Zieger H; Stanley ER; Heuer H; Martini R
Brain; 2012 Jan; 135(Pt 1):88-104. PubMed ID: 22094537
[TBL] [Abstract][Full Text] [Related]
6. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
7. Role of immune cells in animal models for inherited neuropathies: facts and visions.
Mäurer M; Kobsar I; Berghoff M; Schmid CD; Carenini S; Martini R
J Anat; 2002 Apr; 200(4):405-14. PubMed ID: 12090406
[TBL] [Abstract][Full Text] [Related]
8. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of X-linked Charcot-Marie-Tooth disease.
Kleopa KA; Scherer SS
Neuromolecular Med; 2006; 8(1-2):107-22. PubMed ID: 16775370
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
[TBL] [Abstract][Full Text] [Related]
12. Nonuniform molecular features of myelinating Schwann cells in models for CMT1: distinct disease patterns are associated with NCAM and c-Jun upregulation.
Klein D; Groh J; Wettmarshausen J; Martini R
Glia; 2014 May; 62(5):736-50. PubMed ID: 24526449
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy.
Fischer S; Kleinschnitz C; Müller M; Kobsar I; Ip CW; Rollins B; Martini R
Mol Cell Neurosci; 2008 Feb; 37(2):359-66. PubMed ID: 18326085
[TBL] [Abstract][Full Text] [Related]
14. Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A.
Kobsar I; Hasenpusch-Theil K; Wessig C; Müller HW; Martini R
J Neurosci Res; 2005 Sep; 81(6):857-64. PubMed ID: 16041800
[TBL] [Abstract][Full Text] [Related]
15. Role of immune cells in animal models for inherited peripheral neuropathies.
Wang Ip C; Kroner A; Fischer S; Berghoff M; Kobsar I; Mäurer M; Martini R
Neuromolecular Med; 2006; 8(1-2):175-90. PubMed ID: 16775375
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.
Freidin M; Asche-Godin S; Abrams CK
Exp Neurol; 2015 Jan; 263():339-49. PubMed ID: 25447941
[TBL] [Abstract][Full Text] [Related]
17. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.
Kobsar I; Berghoff M; Samsam M; Wessig C; Mäurer M; Toyka KV; Martini R
Brain; 2003 Apr; 126(Pt 4):804-13. PubMed ID: 12615640
[TBL] [Abstract][Full Text] [Related]
18. c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy.
Hantke J; Carty L; Wagstaff LJ; Turmaine M; Wilton DK; Quintes S; Koltzenburg M; Baas F; Mirsky R; Jessen KR
Brain; 2014 Nov; 137(Pt 11):2922-37. PubMed ID: 25216747
[TBL] [Abstract][Full Text] [Related]
19. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.
Vavlitou N; Sargiannidou I; Markoullis K; Kyriacou K; Scherer SS; Kleopa KA
J Neuropathol Exp Neurol; 2010 Sep; 69(9):945-58. PubMed ID: 20720503
[TBL] [Abstract][Full Text] [Related]
20. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
